Product Name: EID3 antibody [N1C1]
Applications: WB
Predicted Target Size: 38 kDa (note) (2)
Positive Controls: IMR32
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: EP300 interacting inhibitor of differentiation 3
Background: Act as a repressor of nuclear receptor-dependent transcription possibly by interfering with CREBBP-dependent coactivation. May function as a coinhibitor of other CREBBP/EP300-dependent transcription factors.
Synonyms: FLJ25832 antibody, NSE4B antibody, NSMCE4B antibody, EID3 antibody, EP300-interacting inhibitor of differentiation 3 antibody, E1A-like inhibitor of differentiation 3 antibody, EID-1-like inhibitor of differentiation 3 antibody, EID-3 antibody, EP300 interacting inhibitor of differentiation 3 antibody
Cellular Localization:
CAS NO: 1082743-70-1
Product: Linagliptin
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human EID3. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22962259?dopt=Abstract
